000 | 01954 a2200529 4500 | ||
---|---|---|---|
005 | 20250518060509.0 | ||
264 | 0 | _c20191120 | |
008 | 201911s 0 0 eng d | ||
022 | _a1524-4563 | ||
024 | 7 |
_a10.1161/HYPERTENSIONAHA.119.13184 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAustdal, Marie | |
245 | 0 | 0 |
_aMetabolomics Identifies Placental Dysfunction and Confirms Flt-1 (FMS-Like Tyrosine Kinase Receptor 1) Biomarker Specificity. _h[electronic resource] |
260 |
_bHypertension (Dallas, Tex. : 1979) _c11 2019 |
||
300 |
_a1136-1143 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aEnzyme-Linked Immunosorbent Assay _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFetal Growth Retardation _xblood |
650 | 0 | 4 | _aHospitals, University |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLinear Models |
650 | 0 | 4 | _aMetabolomics |
650 | 0 | 4 | _aNorway |
650 | 0 | 4 |
_aPlacenta Diseases _xdiagnosis |
650 | 0 | 4 |
_aPlacenta Growth Factor _xblood |
650 | 0 | 4 |
_aPre-Eclampsia _xblood |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aPregnancy Outcome |
650 | 0 | 4 | _aPregnancy, High-Risk |
650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xmetabolism |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-1 _xmetabolism |
700 | 1 | _aSilva, Gabriela Brettas | |
700 | 1 | _aBowe, Sophie | |
700 | 1 | _aThomsen, Liv Cecilie Vestrheim | |
700 | 1 | _aTangerås, Line Haugstad | |
700 | 1 | _aBjørge, Line | |
700 | 1 | _aBathen, Tone Frost | |
700 | 1 | _aIversen, Ann-Charlotte | |
773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 74 _gno. 5 _gp. 1136-1143 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/HYPERTENSIONAHA.119.13184 _zAvailable from publisher's website |
999 |
_c30086714 _d30086714 |